Full Text
The Full Text of this article is available as a PDF (242.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Avorn J., Chen M., Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982 Jul;73(1):4–8. doi: 10.1016/0002-9343(82)90911-1. [DOI] [PubMed] [Google Scholar]
- Baird Patricia. Getting it right: industry sponsorship and medical research. CMAJ. 2003 May 13;168(10):1267–1269. [PMC free article] [PubMed] [Google Scholar]
- Bekelman Justin E., Li Yan, Gross Cary P. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003 Jan 22;289(4):454–465. doi: 10.1001/jama.289.4.454. [DOI] [PubMed] [Google Scholar]
- Bekelman Justin E., Li Yan, Gross Cary P. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003 Jan 22;289(4):454–465. doi: 10.1001/jama.289.4.454. [DOI] [PubMed] [Google Scholar]
- Bero L. A., Rennie D. Influences on the quality of published drug studies. Int J Technol Assess Health Care. 1996 Spring;12(2):209–237. doi: 10.1017/s0266462300009582. [DOI] [PubMed] [Google Scholar]
- Bodenheimer T. Uneasy alliance--clinical investigators and the pharmaceutical industry. N Engl J Med. 2000 May 18;342(20):1539–1544. doi: 10.1056/NEJM200005183422024. [DOI] [PubMed] [Google Scholar]
- Campbell P. Declaration of financial interests. Nature. 2001 Aug 23;412(6849):751–751. doi: 10.1038/35090688. [DOI] [PubMed] [Google Scholar]
- Davidoff F., DeAngelis C. D., Drazen J. M., Nicholls M. G., Hoey J., Højgaard L., Horton R., Kotzin S., Nylenna M., Overbeke A. J. Sponsorship, authorship, and accountability. N Engl J Med. 2001 Sep 13;345(11):825–827. doi: 10.1056/NEJMed010093. [DOI] [PubMed] [Google Scholar]
- DiMasi Joseph A., Hansen Ronald W., Grabowski Henry G. The price of innovation: new estimates of drug development costs. J Health Econ. 2003 Mar;22(2):151–185. doi: 10.1016/S0167-6296(02)00126-1. [DOI] [PubMed] [Google Scholar]
- Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA. 1990 Mar 9;263(10):1385–1389. [PubMed] [Google Scholar]
- Dieppe P. A., Frankel S. J., Toth B. Is research into the treatment of osteoarthritis with non-steroidal anti-inflammatory drugs misdirected? Lancet. 1993 Feb 6;341(8841):353–354. doi: 10.1016/0140-6736(93)90147-9. [DOI] [PubMed] [Google Scholar]
- Djulbegovic B., Lacevic M., Cantor A., Fields K. K., Bennett C. L., Adams J. R., Kuderer N. M., Lyman G. H. The uncertainty principle and industry-sponsored research. Lancet. 2000 Aug 19;356(9230):635–638. doi: 10.1016/S0140-6736(00)02605-2. [DOI] [PubMed] [Google Scholar]
- Dukes M. N. Graham. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23;360(9346):1682–1684. doi: 10.1016/S0140-6736(02)11599-6. [DOI] [PubMed] [Google Scholar]
- Elliott C. Pharma buys a conscience. 2001 Sep 24-Oct 8Am Prospect. 12(17):16–20. [PubMed] [Google Scholar]
- Elliott C. Throwing a bone to the watchdog. Hastings Cent Rep. 2001 Mar-Apr;31(2):9–12. [PubMed] [Google Scholar]
- Haber E. Industry and the university. Nat Biotechnol. 1996 Apr;14(4):441–442. doi: 10.1038/nbt0496-441. [DOI] [PubMed] [Google Scholar]
- Healy D. Good science or good business? Hastings Cent Rep. 2000 Mar-Apr;30(2):19–22. [PubMed] [Google Scholar]
- Henry David, Lexchin Joel. The pharmaceutical industry as a medicines provider. Lancet. 2002 Nov 16;360(9345):1590–1595. doi: 10.1016/S0140-6736(02)11527-3. [DOI] [PubMed] [Google Scholar]
- Lewis S., Baird P., Evans R. G., Ghali W. A., Wright C. J., Gibson E., Baylis F. Dancing with the porcupine: rules for governing the university-industry relationship. CMAJ. 2001 Sep 18;165(6):783–785. [PMC free article] [PubMed] [Google Scholar]
- Lexchin Joel, Bero Lisa A., Djulbegovic Benjamin, Clark Otavio. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003 May 31;326(7400):1167–1170. doi: 10.1136/bmj.326.7400.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nathan David G., Weatherall David J. Academic freedom in clinical research. N Engl J Med. 2002 Oct 24;347(17):1368–1371. doi: 10.1056/NEJMsb020394. [DOI] [PubMed] [Google Scholar]
- Rochon P. A., Gurwitz J. H., Simms R. W., Fortin P. R., Felson D. T., Minaker K. L., Chalmers T. C. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 1994 Jan 24;154(2):157–163. [PubMed] [Google Scholar]
- Rothman K. J. Conflict of interest. The new McCarthyism in science. JAMA. 1993 Jun 2;269(21):2782–2784. doi: 10.1001/jama.269.21.2782. [DOI] [PubMed] [Google Scholar]
- Schulman Kevin A., Seils Damon M., Timbie Justin W., Sugarman Jeremy, Dame Lauren A., Weinfurt Kevin P., Mark Daniel B., Califf Robert M. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med. 2002 Oct 24;347(17):1335–1341. doi: 10.1056/NEJMsa020349. [DOI] [PubMed] [Google Scholar]
- Somerville Margaret A. A postmodern moral tale: the ethics of research relationships. Nat Rev Drug Discov. 2002 Apr;1(4):316–320. doi: 10.1038/nrd773. [DOI] [PubMed] [Google Scholar]
- Stelfox H. T., Chua G., O'Rourke K., Detsky A. S. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998 Jan 8;338(2):101–106. doi: 10.1056/NEJM199801083380206. [DOI] [PubMed] [Google Scholar]
- Thompson D. F. Understanding financial conflicts of interest. N Engl J Med. 1993 Aug 19;329(8):573–576. doi: 10.1056/NEJM199308193290812. [DOI] [PubMed] [Google Scholar]
- van Kolfschooten Frank. Conflicts of interest: can you believe what you read? Nature. 2002 Mar 28;416(6879):360–363. doi: 10.1038/416360a. [DOI] [PubMed] [Google Scholar]